Natural β-phosphodiester 16mer and 15mer antisense oligonucleotides targeted against the HIV-1 and HIV-2 TAR RNAs respectively were previously described as sequence-specific inhibitors of in vitro retroviral reverse transcription. In this work, we tested chemically modified oligonucleotide analogues: α-phosphodiester, 
INTRODUCTION
Reverse transcription of the RNA retroviral genome takes place in the cytoplasm of infected cells, more precisely in the capsid structure which has lost the viral membrane. The first step of viral replication, reverse transcription, is catalysed by an RNA-dependent DNA polymerase or reverse transcriptase (RT), which copies the RNA genome into a first (-) DNA strand. This DNA is subsequently used as template for the synthesis of a double-stranded DNA. The proviral DNA is then integrated into the genome of the infected cells by several reactions catalysed by another viral encoded enzyme, the integrase (IN). All the steps leading to proviral DNA synthesis are catalysed by RT, which possesses, in addition to the RNA-and DNA-dependent DNA polymerase activities, an RNase H activity which is crucial during the replication process (for a recent review of RT see 1). Synthesis of the (-) DNA strand by RT is primed by a cellular tRNA partially annealed to a complementary region of the retroviral RNA genome, the primer binding site (PBS) (reviewed in 2).
Several approaches have been used to inhibit reverse transcription. We intend to arrest retroviral replication by using antisense oligodeoxyribonucleotides (ODNs). The antisense strategy can be used to block various viral replication steps in which nucleic acids may play an important role (reviewed in [3] [4] [5] . Some antisense ODNs are currently in the advanced stages of clinical trials in view of their potential therapeutic use (6) .
We have previously shown that natural phosphodiester ODNs targeted to the prePBS, U 5 and TAR HIV-1 regions (Fig. 1A) are strong inhibitors of reverse transcription in cell-free assays and in virus-infected human cells (7) (8) (9) . This inhibition results both from a specific blockage of cDNA synthesis and from the RNase H activity of RT on the duplex formed by the RNA genome and the antisense ODN. A similar effect was described using avian and murine RTs and globin mRNA as template (10) . The work reported here is focused on the effect of antisense ODNs targeted against the TAR region which is located at the 5′-end of HIV-1 RNA (Fig. 1A) . While this work was performed exclusively with HIV-1 MAL RNA, it is important to point out that the secondary structure of the 5′-region of the HIV-1 MAL RNA has been described as showing some differences from other isolates (11) (12) (13) . The TAR element plays a crucial role in transcription of the integrated retrovirus by interaction with the viral encoded Tat protein (11) and with cellular proteins (15) . Different ODNs have been used to interfere with the Tat-TAR interaction acting directly on this retroviral protein (16) . 
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However, few studies have been performed with antisense ODNs targeted directly against the HIV-1 TAR RNA region (7, 8, 17) . To be efficient inhibitors, anti-TAR ODNs have to compete with the highly stable TAR stem-loop structure (18) (19) (20) . Figure 1B presents the secondary structure of the HIV-1 MAL TAR stemloop and the hybridization site for the antisense ODNs used in this study.
The stability of natural ODNs is rather low because of nucleases present in both the extracellular and intracellular compartments (21) . In this work we have used chemically modified ODNs, which are known to be more resistant to nucleases and have a more efficient cell uptake (4,22; Fig. 2 ). In order to find oligomers with increased inhibitory effect compared with the previously described β-phosphodiester anti-TAR ODNs (7), we investigated the effect of α-phosphodiester, phosphorothioate, methylphosphonate (MP), peptide nucleic acid (PNA), 2′-O-methyl and (N3′-P5′) phosphoramidate (NP) oligomers on HIV-1 reverse transcription. These modified molecules do not elicit RNase H activity of the RT (23) (24) (25) , except in the case of phosphorothioate ODNs (26) .
The α-phosphodiester (α-PO) antisense ODNs anneal in a parallel orientation with the target RNA strand (27) . However, the stability of the hybrid is decreased when compared with the unmodified phosphodiester duplex. The α-PO ODNs have been shown to inhibit the initiation of β-globin mRNA translation (28) . Another interesting modification concerns the widely used phosphorothioate (PS) compounds. Although PS ODNs were described as interacting non-specifically with proteins (29, 30) , there are several reports showing sequence-specific antisense effects of PS ODNs on HIV-1 RNA targets (31) (32) (33) . MPs are non-charged molecules (34) . They form low stability hybrids with RNA when compared with PO ODNs. PNA molecules are made of 2-aminoethyl glycine units and form a very stable duplex with DNA or RNA strands, as well as a triplex structure with double-stranded DNA (35, 36) . PNA are resistant to both nucleases and proteases (37) . The other modified ODNs, the 2′-O-methyl derivatives (38) and the NP molecules (39) form duplexes of high stability with complementary RNA molecules. Surprisingly, the duplex formed between NP and RNA molecules present an A-type helical structure (40) . Phosphoramidates were reported to efficiently block the elongation step in translation (41) . They are extremely promising inhibitors as antisense agents, because of their high affinity and specificity for a given target (42) .
In this study we show that several of the above-mentioned modified ODNs are very strong inhibitors of in vitro HIV-1 reverse transcription as compared with the unmodified phosphodiester ODNs previously used (9, 10) .
MATERIALS AND METHODS

Materials
Proteins. HIV-1 RT p66/p51 was expressed in transformed yeast cells and purified as described previously (43 
Methods
In vitro HIV-1 RNA synthesis. The plasmid pmCG6 containing the nucleotide fragment 1-4005 of HIV-1 (MAL) in pSP64 was a kind gift of Dr J.-L. Darlix (INSERM, Lyon, France). Escherichia coli HB 101 (1035) rec A-was used for plasmid amplification. After digestion of the HIV-1 MAL clone with HincII (position 521) and in vitro transcription using the T7 RNA polymerase system, we obtained RNAs starting at position +1 of the MAL sequence. The nucleotide sequence was checked and was shown to be the same as that of the original clone (44) . Three micrograms of linearized plasmid DNA were transcribed in 0.1 ml of 40 mM Tris-HCl (pH 8.0), 8 mM MgCl 2 , 10 mM spermidine, 25 mM NaCl, 10 mM dithiothreitol (DTT), 0.5 mM each rNTP, 100 U of T7 RNA polymerase in the presence of 20 U of RNasin, for 90 min at 37_C. After treatment with 12 U of RNase-free DNase I for 10 min at 37_C, RNA transcripts were extracted with 1 vol of phenol/ chloroform/isoamyl alcohol (24/24/1) and with 1 vol of chloroform and then precipitated with 2.5 vol of ethanol and 0.3 M ammonium acetate. The purity and the integrity of RNAs were checked by UV light after electrophoresis on a 1% agarose gel stained with ethidium bromide.
Reverse transcription on retroviral HIV-1 RNA template. Reverse transcription was performed in a total volume of 10 µl containing 50 mM Tris-HCl (pH 8.0), 6 mM MgCl 2 , 2 mM DTT, 30 mM NaCl, 100 nM HIV-1 RNA, 0.1 mM each dNTP, varying concentrations of antisense ODNs, 1.5 µM synthetic primer complementary to the primer binding site (PBS) of HIV-1 RNA and 5 µCi of [α-32 P]dCTP (3000 Ci/mmol). Template and primer and antisense oligonucleotides were hybridized for 15 min at 37_C and then dNTP, [α-32 P]dCTP, 150 nM RT and 0.2 U of RNasin were added. The incubation was continued for 45 min at 37_C and the reaction was stopped by adding 3 µl of electrophoresis loading buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 0.1% bromophenol blue, 0.1% xylene cyanol, 30% glycerol). Reaction products were analyzed on 6% polyacrylamide-TBE-7 M urea denaturing gels. Gels were autoradiographed and films were scanned using the NIH Image program (Macintosh). Nucleic Acids Research, 1998, Vol. 26 
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Reverse transcription on synthetic poly(A)·oligo(dT).
The ODNs used in a large concentration range were preincubated for 15 min at 37_C in 50 µl of reaction buffer containing 50 mM Tris-HCl (pH 8.0), 5 mM Mg acetate, 80 mM KCl, 4 mM DTT, 20 µM dTTP, 0.5 µCi of [ 3 H]dTTP (56 Ci/mmol), 20 mg/ml of (20:1) poly(A)·oligo(dT). Then, 150 nM RT was added and the reaction mixture was incubated for 10 min at 37_C. The reaction was stopped by addition of 10% trichloroacetic acid and the mixture was filtered through nitrocellulose membranes. Radioactivity was counted in a toluene/PPO/POPOP scintillation mixture.
Gel mobility shift assay. The plasmid pmCG6 (above) after digestion by Alw44I was transcribed in vitro by T7 RNA polymerase in the presence of [α-32 P]CTP (3000 Ci/mmol). The labelled 274 nt RNA was purified by elution from a 4.5% denaturing polyacrylamide gel. Labelled RNA (5 nM) was incubated in 7 µl of reverse transcription buffer with different ODN concentrations for 15 min at 37_C. Incubation was stopped by addition of 3 µl of electrophoresis loading buffer (10 mM Tris-HCl, pH 8.0, 0.1% bromophenol blue, 0.1% xylene cyanol, 30% glycerol), samples were loaded directly on a non-denaturing 4% polyacrylamide gel and run at low and controlled voltage for 7 h at room temperature. The gel was autoradiographed and scanned using the Image Quant program for the PhosphorImager (Molecular Dynamics). The K d was calculated from a double-inverted representation according to the equation
where [ODN-RNA] is the concentration of the complex.
For the k ass determination, RNA (100 nM, 10 4 c.p.m./pmol sp. act.) was incubated at 37_C with various concentrations of anti-TAR oligonucleotide in at least a 10-fold excess, for different times from 30 s to 1 h. The reaction was arrested by keeping the samples on ice before loading on the gel. The amount of unbound RNA in each lane was used to calculate the constants (k obs ) of the pseudo-first order reaction for each ODN concentration according to the equation
The association rate constant k ass was then derived from the equation
where [RNA] and [ODN] are the RNA and oligonucleotide concentrations, respectively.
RESULTS
Inhibition of HIV-1 reverse transcription by PS, MP and α-PO anti-TAR ODNs
We investigated the effect of various anti-TAR ODNs on reverse transcription. The studies were performed using an 18mer anti-PBS synthetic ODN as primer, but similar results were obtained when the HIV-1 natural primer tRNA Lys,3 was used. The specific inhibition of HIV-1 reverse transcription by a given antisense oligonucleotide is visualized by the decrease and eventual disappearance of the strong-stop 196 nt band and the simultaneous appearance of the 161 nt blockage cDNA band (Fig. 3A) . Both the RT primer and the anti-TAR ODN can be used by RT to initiate cDNA synthesis, leading to bands of 196 and 35 nt, respectively. The appearance of the 35 nt band confirms annealing of the anti-TAR ODN to the RNA target. 
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As previously described, the PO anti-TAR ODN strongly inhibited reverse transcription at 1 µM (Fig. 3B, lane 1) (7) . An IC 50 of 240 nM was determined for the β-PO ODN (Table 1) . When using the 16mer PS anti-TAR ODN, concentrations as low as 5 nM gave an inhibitory effect (lane 3). The inhibition was at least partly due to annealing of the antisense ODN rather than to non-specific protein binding, since the 161 nt blockage band and the 35 nt synthesis band were present (lanes 3 and 4) . In contrast, at concentrations of PS ODN >25 nM (lane 5) the blockage bands disappeared, most probably due to direct inhibition of HIV-1 RT by PS ODNs. A similar sequence-specific antisense inhibition of reverse transcription at low PS ODN concentrations has been described when using a 17mer PS ODN directed against globin mRNA in in vitro experiments (46) .
No inhibition was observed with the MP (lane 6) and α-PO (lane 7) ODNs at concentrations up to 1 µM. However, ∼30% inhibition was obtained with the α-PO anti-TAR ODN at 5 µM, as indicated by the presence of a faint 161 nt blockage band. Non-specific inhibition was observed with the MP anti-TAR ODN at 15 µM concentration. Similar results have been reported for other MP oligomers (51). Since all previous experiments were performed using the HIV-1 MAL isolate (44), we did a similar experiment using the BRU strain, in order to study whether the inhibition of HIV-1 reverse transcription by anti-TAR ODNs was observed with other HIV-1 strains. The HIV-1 BRU TAR stem-loop (45) has the same structure as the HIV-1 MAL region except for the bulge interacting with the Tat protein, which possesses three unpaired pyrimidines, instead of CU in HIV-1 MAL , and some different nucleotides in the TAR loop and stem (52) . Very similar inhibition patterns of reverse transcription were obtained when using either the 17mer targeting the HIV-1 BRU TAR region or the 16mer complementary to the HIV-1 MAL TAR (results not shown).
Inhibition of HIV-1 reverse transcription by PNA anti-TAR molecules
We studied the effect of the 16mer anti-TAR ODN synthesized as a PNA derivative. Since PNA is a pseudo-peptide and therefore does not contain a 3′-ribose unit, it cannot be elongated by RT. Thus, PNA annealing can only be visualized by a decrease in the 196 nt cDNA band and the appearance of the 161 nt band. As seen in Figure 4 , concentrations as low as 10 nM of the 16mer PNA anti-TAR oligomer induced a 161 nt blockage band (lane 1). This inhibition increased with the concentration of the PNA oligomer (lanes 1-4). As shown in Table 1 , an IC 50 of 40 nM was determined. At 100 nM (lane 4), no 196 nt band was detected. No inhibition was observed when mismatched and scrambled PNA sequences were tested up to 1 µM (lanes 5 and 6, respectively).
Inhibition of HIV-1 reverse transcription by 2′-O-methyl anti-TAR ODNs
We also investigated the behaviour of other efficient RNA binding agents as inhibitors of reverse transcription. The 2′-O-methyl oligonucleotides present a very high affinity for complementary RNA (38) . As shown in Figure 5 , the 161 nt blockage band was clearly seen at 10 nM modified anti-TAR ODN (lane 2). Total inhibition of strong-stop cDNA synthesis was observed at 50 nM (lane 3), with an IC 50 of 20 nM (Table 1 ). The inhibition was specific, as no effect was observed with the mismatched (lanes 5 and 6) and the scrambled (lanes 7 and 8) 2′-O-methyl oligomers, respectively, at 100 nM and 1 µM. No 35 nt synthesis band was observed from the 3′-OH end of the 2′-O-methyl anti-TAR oligonucleotides. 
Inhibition of HIV-1 reverse transcription by the NP ODNs
NP ODNs are new promising antisense agents, given their ability to anneal to complementary RNA and their fast and efficient uptake by animal cells (35) . Total reverse transcription inhibition with the 16mer NP anti-TAR ODN was obtained at a concentration as low as 5 nM (Fig. 6, lane 2) . Thus, the in vitro inhibition by NP ODN is the strongest obtained with the different modified anti-TAR ODNs used in this work, with an IC 50 value of 3 nM (Table 1) . Moreover, it is sequence-specific, since no inhibition was observed with the mismatched (lanes 6 and 7) and the scrambled (lanes 8 and 9) analogues, respectively, at 100 nM and 1 µM. In spite of a strong duplex formation between the 16mer NP ODN and the HIV-1 TAR region, we noticed the absence of the 35 nt synthesis cDNA band, indicating that the 16mer NP anti-TAR ODN cannot prime reverse transcription in spite of having a 3′-OH group (Fig. 7B, lane 6) , in contrast to PO anti-TAR ODN (Fig. 7, lane 5) . Under the same conditions, the NP anti-prePBS and the anti-U 5 ODNs, carrying a 3′-OH group, allowed a significant initiation of cDNA synthesis by HIV-1 RT (Fig. 7B, lanes 2 and 4, respectively) ; this high priming efficiency is observed with anti-prePBS (173 nt cDNA band, Fig. 7A ) and anti-U 5 (128 nt strong-stop cDNA) analogues at low concentration compared with PO ODNs (lanes 1 and 3, respectively) . In the same way, no priming was observed with the 2′-O-methyl molecules targeted against the TAR region (results not shown). A possible explanation for the lack of initiation when the 2′-O-methyl or the 16mer NP anti-TAR ODN were annealed to the TAR region may be that either RT does not bind this modified duplex or RT binds, but does not extend the modified primer. Experiments to explain this observation are in progress.
We obtained a similar inhibition of reverse transcription with a 15mer NP anti-TAR ODN targeted against the HIV-2 TAR proximal stem-loop (results not shown).
Direct inhibition of HIV-1 RT by antisense ODNs
The reverse transcription experiments described above were performed in an assay using the retroviral RNA as a template. To evaluate interaction of ODNs with HIV-1 RT, we studied the effect of the different oligomers in a synthetic primer-template system in order to determine whether direct binding of ODNs to RT could account for some of the observed inhibitory effect. We used the ODN (dT [12] [13] [14] [15] [16] [17] [18] ) as a primer annealed to a poly(A) template and we followed the incorporation of [ 3 H]dTTP by HIV-1 RT. As the anti-TAR ODNs used in this experiment were not complementary to the poly(A) template, inhibition of reverse transcription can be due only to direct binding of the ODN to RT. As seen in Figure 8 , 
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the β-PO ODN presents a very low direct inhibitory effect with an IC 50 of 240 nM. PS ODN inhibits >45% of the RT activity at 100 nM, while the inhibition was >70% at 1 µM. A similar strong non-specific inhibitory effect was observed in a synthetic ODN-primed cDNA synthesis using β-globin mRNA as template (unpublished results). As mentioned above, direct interaction of the PS ODN with several cellular (29, 53) and viral proteins (33,51) has been previously described. However, a sequence-specific inhibition was observed with the PS anti-TAR ODN only up to 25 nM (Fig. 3B) . With the PNA molecule a low level of direct inhibition was observed (∼20% at 1 µM), in agreement with the slight decrease in the intensity of the 161 nt blockage band observed in Figure 4 (lane 4). In contrast, no direct inhibition by the 2′-O-methyl or the 16mer NP anti-TAR ODNs was obtained with concentrations up to 1 µM (Fig. 8) . 
Gel mobility shift of 16mer β-PO, 2′-O-methyl and NP anti-TAR ODN-RNA target duplexes
We performed band shift assays in order to quantify the affinity of the chemically modified duplex forming ODNs. In Figure 9 , various concentrations of anti-TAR ODN were used. We observed (lanes 1-4) that β-PO molecules have a low affinity for the RNA target, since at 1 µM antisense ODN the labelled RNA band is only partially shifted (lane 4); the K d determined for the PO anti-TAR ODN is ∼600 nM. In contrast, when using the 2′-O-methyl anti-TAR analogue (lanes 5-8), a band corresponding to the duplex was already observed at 5 nM antisense oligonucleotide (lane 6) and at 50 nM the shift of the labelled RNA band was practically complete (lane 8). The K d for this modified antisense oligo is estimated to be ∼20 nM. A similar result was obtained with phosphoramidate anti-TAR ODN (lanes 9-12), except that a duplex is already visualized at 1 nM antisense ODN (lane 9) and a lower K d (5 nM) was calculated compared with the 2′-O-methyl molecule. Moreover, duplex formation was specific, as no shift was obtained when using mismatched or scrambled PO, 2′-O-methyl or NP anti-TAR ODNs.
Some kinetic experiments were also performed to determine the association rate constants of these different ODNs (Materials and Methods). Association rate constants (k ass ) of 1.7 × 10 3 with PO ODN, of 7.2 × 10 4 with 2′-O-methyl ODN and of 1.1 × 10 5 /M/s with NP ODN anti-TAR were obtained.
DISCUSSION
Some modified ODNs have been proven to be resistant to the action of cellular nucleases. Some of these chemically modified oligomers have a stronger affinity for their complementary nucleic acid target. In this work we have tested their inhibitory effect on HIV-1 reverse transcription. Among the modified ODNs used, PS is the only one which is able to elicit the RNase H activity associated with RT. A sequence-specific inhibitory effect was observed at low concentration of the PS anti-TAR antisense oligonucleotide in our in vitro cDNA synthesis system; however, at concentrations >25 nM PS ODN, the inhibition is most likely due to a non-specific effect, by direct binding of the PS anti-TAR ODN to RT (Fig. 8) . This result points to the requirement for appropriate control experiments to distinguish between the non-specific and the sequence-specific effects of the PS molecules (54) (55) (56) . Chimeric PS/PO molecules were recently designed to reduce the undesirable side-effects of these agents (57) .
The lack of inhibition observed with the α-PO anti-TAR oligonucleotide may be due to the low affinity beween the α-derivatives and the structured TAR region or to the displacement of the annealed ODN by the reverse transcription complex. We favour the second hypothesis considering that the gel band shift experiment showed that the α-PO anti-TAR ODN was able to bind to its RNA target with a K d of 770 nM (results not shown). The absence of an inhibitory effect of MP ODNs could be explained by the lower stability of the duplex MP-RNA compared with the PO; some chimeric PO/MP analogues able to induce RNase H activity have been described (58, 59 ).
An important specific inhibition was observed with the 16mer PNA anti-TAR oligomer. Compared with the PO ODN (7), the IC 50 value for the PNA derivative is six times lower. As PNA-RNA duplexes do not induce digestion of the RNA moiety by RNase H, we conclude that inhibition involves a sequencespecific blockage effect, due to melting out of the TAR stem-loop structure. Efficient inhibition of in vitro reverse transcription has been reported with a PNA ODN targeted against the gag gene (60). However, the lack of penetration of PNA derivatives across the cell membrane decreases the potential use of these antisense agents for therapeutical applications. Nevertheless, progress is expected in improving PNA penetration to make feasible the in vivo use of these agents. Recently, chimeric molecules (PO/PNA) have been described as showing a good rate of cell penetration (61) .
The 2′-O-methyl and the NP ODNs are able to very efficiently block reverse transcription at concentrations in the nanomolar range; the high stability of the duplex formed with the target RNA is most probably responsible for this strong effect. The 2′-O-methyl ODNs were previously shown to be efficient inhibitors of AMV RT-primed reverse trancription using globin mRNA as the template/primer duplex (62) . The binding parameters (K d and k ass ) of the 2′-O-methyl and NP anti-TAR modified ODNs are also in complete agreement with the cDNA synthesis inhibition rates observed. Compared with the high IC 50 values observed with the β-PO anti-TAR 16mer, the 2′-O-methyl and the NP oligomers are ∼12 and 80 times more efficient as antisense agents, respectively. In addition, experiments were performed with an NP anti-TAR ODN (15mer) complementary to the HIV-2 TAR region using the homologous HIV-2 RT. A similar inhibition to that obtained with HIV-1 was obtained (to be published). Thus, the sequence-specific inhibition by NP antisense agents against HIV-1 and HIV-2 TAR elements shows the efficiency and the promising future of the antisense strategy to inhibit retroviral reverse transcription. Indeed, the NP anti-TAR ODN presents ∼120 times higher affinity than PO ODNs and four times higher than the 2′-O-methyl agent. The k ass also reflects a faster association of the NP molecule with the RNA target as compared with the 2′-O-methyl ODN (1.5 times) and, more strikingly, with the PO ODN (65 times). The low value of k ass observed could be explained by the fact that the antisense ODNs are targeted to a stable RNA secondary structure, the TAR stem-loop. Indeed, similar k ass were previously observed when targeting an RNA structure by an oligoribonucleotide (63, 64) . The two complementary partners likely form a base-specific complex with only a few bases of the RNA loop target, followed by formation of an extended duplex (64) . When the 2′-O-methyl or the NP agents are involved in the pre-complex, this structure leads more often or faster to the extended duplex than when the PO ODN is used. The pre-complex is more stable for an RNA-RNA-like duplex (with 2′-O-methyl or NP anti-TAR ODNs) than for a RNA-DNA duplex with PO ODN. Even if we have verified that the 16mer PO ODN is not able to adopt an intramolecular structure (result not shown), it is however possible that the 2′-O-methyl and NP molecules form a self-associated secondary structure by complementarity of the two G-C base pairs at the bottom of the loop. It can be speculated that a loop-loop interaction with the TAR RNA could take place only in the case of these two modifications, explaining the higher k ass observed. As a good correlation has previously been described between some physical parameters and the cellular efficiency of antisense ODNs, the 2′-O-methyl and NP ODNs may be considered as potential specific antisense agents (65, 66) . Studies of viral replication inhibition are in progress in HIV-1-infected cell cultures to test the penetration, the nuclease resistance and the inhibitory effect of NP molecules. In addition, this 16mer 2′-O-methyl-PO anti-TAR ODN were also tested against the Tat protein-TAR RNA interaction. They are able to efficiently interfere with specific binding of the Tat protein to the TAR element (B.Mestre, M.Singh, F.Boulmé, S.Litvak and M.J.Gait, submitted for publication) and may interfere with the reported effect of TAR RNA on reverse transcription (67) . Moreover, some nucleic acid binding proteins in the cell may stabilize this anti-TAR RNA duplex, as already described for p53 protein (68) and other viral (69) and cellular proteins (70) . Our unpublished results indicate that the HIV-1 nucleocapsid protein (NCp7), in spite of the fact that this protein covers the genomic RNA, does not interfere with use of the antisense strategy and facilitates the use of these agents.
